Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC40552(R)-AcenocoumarolCAS: 66556-77-2纯度: >98.00%
Longer-lived enantiomer of the anticoagulant acenocoumarol
- GC40553(S)-AcenocoumarolCAS: 66556-78-3纯度: >98.00%
Shorter-lived enantiomer of the anticoagulant acenocoumarol
- GC405856α-Prostaglandin I1CAS: 62777-90-6纯度: >99.00%
A potent inhibitor of ADP-induced platelet aggregation
- GC40590ent-8-iso-15(S)-Prostaglandin F2αCAS: 214748-66-0纯度: >98.00%
A vasoconstrictor and inhibitor of platelet aggregation
- GC40629DimethoxycurcuminCAS: 160096-59-3纯度: >99.00%
A derivative of curcurmin with anti-inflammatory and antioxidant activities
- GC4074513,14-dehydro-15-cyclohexyl CarbaprostacyclinCAS: 145375-81-1纯度: >98.00%
A stable PGI 2 analog
- GC407993-hydroxy-3-Methylglutaric anhydrideCAS: 34695-32-4纯度: >95.00%
A precursor in the synthesis of HMG-CoA
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC40457 | 19(R)-HETE | 115461-39-7 | >98.00% | |
A potent vasodilator of renal arterioles | ||||
| GC40467 | (±)11-HETE | 73804-65-6 | >98.00% | |
A non-enzymatically derived oxylipin | ||||
| GC40485 | Icosabutate | 1253909-57-7 | >95.00% | |
A synthetic ω-3 PUFA | ||||
| GC40503 | 2-HOBA | 932-30-9 | >95.00% | |
An isoketal scavenger | ||||
| GC40529 | 7-hydroxy Warfarin | 17834-03-6 | - | |
A phase I metabolite of (-)-warfarin | ||||
| GC40535 | 6,15-diketo-13,14-dihydro Prostaglandin F1α | 63983-53-9 | >98.00% | |
A PGI 2 metabolite | ||||
| GC40541 | (±)9-HODE | 98524-19-7 | >98.00% | |
A monohydroxy fatty acid derived from linoleic acid | ||||
| GC40552 | (R)-Acenocoumarol | 66556-77-2 | >98.00% | |
Longer-lived enantiomer of the anticoagulant acenocoumarol | ||||
| GC40553 | (S)-Acenocoumarol | 66556-78-3 | >98.00% | |
Shorter-lived enantiomer of the anticoagulant acenocoumarol | ||||
| GC40555 | Tiopronin | 1953-02-2 | >98.00% | |
Tiopronin is an antioxidant that has diverse biological activities. | ||||
| GC40585 | 6α-Prostaglandin I1 | 62777-90-6 | >99.00% | |
A potent inhibitor of ADP-induced platelet aggregation | ||||
| GC40586 | 6β-Prostaglandin I1 | 62770-50-7 | >99.00% | |
A stable PGI 2 analog with reduced potency | ||||
| GC40590 | ent-8-iso-15(S)-Prostaglandin F2α | 214748-66-0 | >98.00% | |
A vasoconstrictor and inhibitor of platelet aggregation | ||||
| GC40610 | Prostaglandin D3 | 71902-47-1 | >98.00% | |
An inhibitor of platelet aggregation | ||||
| GC40624 | MMP-3 Inhibitor VIII | 208663-26-7 | >95.00% | |
A selective inhibitor of MMP-3 | ||||
| GC40629 | Dimethoxycurcumin | 160096-59-3 | >99.00% | |
A derivative of curcurmin with anti-inflammatory and antioxidant activities | ||||
| GC40632 | CMS121 | 1353224-53-9 | >98.00% / >98.50% | |
CMS121是一种口服有效的乙酰辅酶A羧化酶1（ACC1）抑制剂。 | ||||
| GC40708 | C2 L-erythro Ceramide (d18:1/2:0) | 150338-90-2 | >98.00% | |
A bioactive sphingolipid | ||||
| GC40709 | C2 L-threo Ceramide (d18:1/2:0) | 143615-69-4 | >98.00% | |
A bioactive sphingolipid | ||||
| GC40745 | 13,14-dehydro-15-cyclohexyl Carbaprostacyclin | 145375-81-1 | >98.00% | |
A stable PGI 2 analog | ||||
| GC40782 | 5(Z),11(Z),14(Z)-Eicosatrienoic Acid | 7019-85-4 | >98.00% | |
A polyunsaturated fatty acid | ||||
| GC40799 | 3-hydroxy-3-Methylglutaric anhydride | 34695-32-4 | >95.00% | |
A precursor in the synthesis of HMG-CoA | ||||
| GC40807 | Levonordefrin | 829-74-3 | >95.00% | |
A vasoconstrictor | ||||
| GC40835 | (±)14(15)-EET methyl ester | - | >98.00% | |
An esterified version of (±)14(15)-EET | ||||